Physician profile
Anthony Sandoval
NPI 1811994429
$5,323.35
in general payments reported to CMS, 2019-2025
31 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $361 · 2021: $827 · 2022: $1,269 · 2023: $749 · 2024: $1,127 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,079.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $970.68 | 2019-2024 | Impella |
| Amgen INC. | $370.50 | 2020-2023 | Repatha |
| Abbott Laboratories | $369.80 | 2019-2023 | Xience Skypoint, Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $362.02 | 2019-2024 | Camzyos, Eliquis |
| Boston Scientific Corporation | $345.02 | 2019-2024 | |
| Edwards Lifesciences Corporation | $288.56 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $246.23 | 2021-2025 | Symplicity G3, Resolute Onyx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $226.73 | 2019-2024 | Lifevest |
| W. L. Gore & Associates, INC. | $226.20 | 2020-2023 | Gore Cardioform Septal Occluder |
| Philips North America LLC | $224.99 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $203.16 | 2020-2024 | |
| Pfizer INC. | $189.26 | 2019-2025 | |
| Cardiovascular Systems INC. | $157.78 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $154.08 | 2022 | |
| Biosense Webster, INC. | $130.66 | 2021-2023 | Na |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $118.50 | 2019-2024 | Xarelto |
| Zoll Circulation INC | $103.00 | 2023 | Downstream Cartridge, Therox Ds2 Console, Catheter |
| Merck Sharp & Dohme LLC | $96.74 | 2025 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.19 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $87.52 | 2019-2024 | Farxiga |
| Regeneron Healthcare Solutions, INC. | $81.06 | 2019 | |
| Terumo Medical Corporation | $62.99 | 2022 | |
| Bardy Diagnostics, INC. | $45.00 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $34.95 | 2023-2024 | Inpefa |
| Cordis US Corp. | $26.76 | 2024 | Mynx Venous Vcd |
| Stryker Corporation | $25.00 | 2019 | |
| Teleflex LLC | $21.91 | 2019 | |
| Alnylam Pharmaceuticals INC. | $18.19 | 2024 | Amvuttra |
| Chiesi USA, INC. | $16.68 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.40 | 2021 | |
| Amarin Pharma, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Sandoval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.